Amgen Inc.

Dividend Per Share TTM ($)	7.76
Forward Annual Dividend Yield	2.75%
Ex Dividend Date (MM/DD/YYYY)	11/16/2022
Dividend Pay Date (MM/DD/YYYY)	12/8/2022
Dividend Yield (TTM)	2.03%
Forward Annual Dividend Rate ($)	7.76
Dividend Payout Ratio	70.00
Dividend Per Share 5 Year CAGR	11.97%

Analyst Estimates

EPS Estimate Current Year ($)	17.64
EPS Estimate Next Year ($)	18.62
EPS Estimate Next Quarter ($)	4.54
EPS Estimate Current Quarter ($)	3.93
Current Target Price ($)	261.33
Next 5 Year Growth Rate (%)	7.1
1 week Ago Target Price ($)	259.93
2 week Ago Target Price ($)	257.60
3 week Ago Target Price ($)	254.00

Financial Health

Cash Flow Per Share TTM ($)	18.05
Current Ratio	1.70
Quick Ratio	1.20
Debt to Equity Ratio (Last Quarter)	10.60
Long term debt per share (Last Quarter)	69.66
F Score	4.0

Technicals

RSI (14 Day)	62.86
14 Day SMA ($)	285.11
14 Day EMA ($)	283.45
Money Flow Index	58.62
Average True Range	6.69
50 Day SMA ($)	260.93
200 Day SMA ($)	246.63
ADX	25.67
MACD	6.13

Growth

Free Cash Flow QoQ Growth	67.34%
Free Cash Flow YoY Growth	-15.25%
Revenue YoY Growth	2.18%
EPS QoQ Growth	63.01%
Revenue QoQ Growth	0.88%
EPS YoY Growth	-16.61%

Profitability

Return on Assets TTM (%)	10.62
Profit Margin TTM (%)	34.4
Return on Equity TTM (%)	115.16
Return on Capital TTM (%)	18.17
Interest Coverage Ratio	6.80
Gross Margin TTM (%)	74.0

Peers

Stock	Dividend	Market Cap (B)	PE	Price ($)
ABBV	0.0401	242 B	33.1	142.53
ABT	0.0147	225 B	32.4	128.05
BIIB		34 B	21.6	221.3
BMY	0.0332	145 B	-27.3	66.19
GILD	0.0444	86 B	11.7	63.76
GSK
ILMN		56 B	57.3	355.92
JNJ	0.0247	450 B	22.1	171.06
LLY	0.0161	238 B	37.4	243.55
PFE	0.0302	298 B	15.1	53.21

News

Financials

Income Statement

Balance Sheet

Cash Flow

AMGN Income Statement

Annual

	Dec-12	Dec-13	Dec-14	Dec-15	Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21
Total revenues	17,265 M	18,676 M	20,063 M	21,662 M	22,991 M	22,849 M	23,747 M	23,362 M	25,424 M	25,979 M
Cost of sales	2,111 M	2,060 M	2,330 M	2,119 M	2,057 M	2,114 M	2,155 M	2,150 M	2,558 M	3,056 M
Gross operating profit	13,440 M	14,846 M	14,905 M	16,717 M	17,730 M	17,726 M	18,432 M	17,848 M	18,081 M	17,843 M

Selling Gen & administrative expense	5,109 M	5,380 M	5,153 M	4,895 M	5,195 M	5,245 M	5,646 M	5,216 M	5,919 M	5,562 M
Research & development expense	3,380 M	4,083 M	4,297 M	4,070 M	3,840 M	3,562 M	3,737 M	4,116 M	4,207 M	4,819 M
Operating income	5,577 M	5,867 M	6,191 M	8,470 M	9,794 M	9,973 M	10,263 M	9,674 M	9,139 M	9,144 M

floaterest income	0	0	0	0	0	0	0	0	0	0
floaterest expense	0	0	0	0	0	0	0	0	0	0
Other income net	0	0	0	0	0	0	0	0	256 M	-1,246 M
Pre-tax Income (EBT)	5,009 M	5,265 M	5,585 M	7,978 M	9,163 M	9,597 M	9,545 M	9,138 M	8,133 M	6,701 M

Income taxes	664 M	184 M	427 M	1,039 M	1,441 M	7,618 M	1,151 M	1,296 M	869 M	808 M
Net income from total operations	4,345 M	5,081 M	5,158 M	6,939 M	7,722 M	1,979 M	8,394 M	7,842 M	7,264 M	5,893 M
Minority floaterest	0	0	0	0	0	0	0	0	0	0
Total net income	4,345 M	5,081 M	5,158 M	6,939 M	7,722 M	1,979 M	8,394 M	7,842 M	7,264 M	5,893 M

Preferred dividends	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net income available for common	4,345 M	5,081 M	5,158 M	6,939 M	7,722 M	1,979 M	8,394 M	7,842 M	7,264 M	5,893 M
Depreciation	1,088 M	1,286 M	2,092 M	2,108 M	2,105 M	1,955 M	1,946 M	2,206 M	3,601 M	3,398 M
Amortization	294 M	0	0	0	0	0	0	0	0	0
Operating income before depreciation (EBITDA)	7,150 M	7,573 M	8,748 M	11,181 M	12,528 M	12,856 M	12,883 M	12,633 M	12,996 M	11,296 M
Total Income available for floaterest expense (EBIT)	0	0	0	0	0	0	0	0	0	0
Basic EPS total	5.61	6.75	6.8	9.15	10.32	2.71	12.7	12.96	12.4	10.34
Diluted EPS total	5.52	6.64	6.7	9.06	10.24	2.69	12.62	12.88	12.31	10.28

<< PREVIOUS STOCK

NEXT STOCK>>

Call: 1-877-778-8358

I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.

Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today

Amgen Inc.

Sector: Healthcare

Industry: Biotechnology

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Valuation

Price per Sales TTM ($)

Price per Book TTM ($)

PE Ratio (TTM)

Book Value per Share ($)

5 Year PE Range

Returns

7 Day Return

1 Month Return

3 Month Return

1 Year Return

3 Year Return

5 Year Return

YTD Return

Risk

Custom Beta One Year

Custom Beta Three Years

Beneish M Score

Altman Z Score

Ranks

MarketXLS Value Score

MarketXLS Quality Score

MarketXLS Technical Score

MarketXLS Rank

Dividends

Dividend Per Share TTM ($)

Forward Annual Dividend Yield

Ex Dividend Date (MM/DD/YYYY)

Dividend Pay Date (MM/DD/YYYY)

Dividend Yield (TTM)

Forward Annual Dividend Rate ($)

Dividend Payout Ratio

Dividend Per Share 5 Year CAGR

Analyst Estimates

EPS Estimate Current Year ($)

EPS Estimate Next Year ($)

EPS Estimate Next Quarter ($)

EPS Estimate Current Quarter ($)

Current Target Price ($)

Next 5 Year Growth Rate (%)

1 week Ago Target Price ($)

2 week Ago Target Price ($)

3 week Ago Target Price ($)

Financial Health

Cash Flow Per Share TTM ($)

Current Ratio

Quick Ratio

Debt to Equity Ratio (Last Quarter)

Long term debt per share (Last Quarter)

F Score

Technicals

RSI (14 Day)

14 Day SMA ($)

14 Day EMA ($)

Money Flow Index

Average True Range

50 Day SMA ($)

200 Day SMA ($)

ADX

MACD

Growth

Free Cash Flow QoQ Growth

Free Cash Flow YoY Growth

Revenue YoY Growth

EPS QoQ Growth

Revenue QoQ Growth

EPS YoY Growth

Profitability

Return on Assets TTM (%)

Profit Margin TTM (%)

Return on Equity TTM (%)

Return on Capital TTM (%)

Interest Coverage Ratio

Gross Margin TTM (%)

Peers

ABBV

Sector:
Healthcare

Industry:
Biotechnology